NCT06607302View on ClinicalTrials.gov

Ivosidenib in Locally Advanced or Metastatic Cholangiocarcinoma With IDH1 R132 Mutation After at Least One Prior Systemic Treatment - an Observational Study

RecruitingOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

October 8, 2024

Primary Completion Date

December 31, 2027

Study Completion Date

December 31, 2027

Conditions
Cholangiocarcinoma
Trial Locations (2)

Unknown

RECRUITING

Caritas Krankenhaus Bad Mergentheim, Bad Mergentheim

RECRUITING

Onkologisches Versorgungszentrum Berlin MVZ, Berlin

All Listed Sponsors
collaborator

Servier Deutschland GmbH

INDUSTRY

lead

iOMEDICO AG

INDUSTRY